pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,811 catalysts · 5,811 phase readout · 2,343 8k filing · 406 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-03: 0 catalysts2026-08-04: 0 catalysts2026-08-05: 0 catalysts2026-08-06: 0 catalysts2026-08-07: 0 catalysts2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 14 catalysts2026-08-11: 13 catalysts2026-08-12: 17 catalysts2026-08-13: 18 catalysts2026-08-14: 3 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 2 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 11 catalysts2026-10-29: 20 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: grant×type: filing×type: phase readout×clear all
type
  • phase readout5,811
  • 8k filing2,343
  • earnings406
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›ACTIVE_NOT_RECRUITINGphase readoutNCT05968716: Addressing Unmet Social Needs Among Hospitalized Children

Sponsor: University of California, San Francisco. Phase: NA. Conditions: Social Needs Screening, Caregiver-care Team Relationships, Social Needs Status, Child Health Status, Caregiver Health Status, Utilization, Health Care

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05797233: Trial of Anti-CD19 and Anti-CD20 Bicistronic Chimeric Antigen Receptor T Cells for Treating B-Cell Malignancies

Sponsor: National Cancer Institute (NCI). Phase: PHASE1. Conditions: Chronic Lymphocytic Leukemia, B-Cell Chronic Lymphocytic Leukemia, Lymphoma, B-Cell

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06965933: Perioperative Use of Erector Spinae Plane Block (ESPB) and Intravenous Lidocaine Infusion in Anesthetic Management of Spinal Surgery in Children

Sponsor: Saint Petersburg State University, Russia. Phase: PHASE4. Conditions: Regional Anesthesia, Lidocaine Infusion

full page →ctgov ↗
›COMPLETEDphase readoutNCT06613633: Third-generation EGFR-TKI Treatment in Metastatic EGFR-mutant NSCLC

Sponsor: Fudan University. Phase: . Conditions: Third-generation TKI, NSCLC (Advanced Non-small Cell Lung Cancer)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07595133: A Multicenter Clinical Study of Romiplostim N01 in the Treatment of Sepsis-related Thrombocytopenia

Sponsor: Shanghai 10th People's Hospital. Phase: PHASE1. Conditions: Sepsis

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05634252: Undergraduate Skin Cancer Prevention Trial

Sponsor: University of Utah. Phase: PHASE3. Conditions: Skin Cancer

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07678047: Leveraging Project ECHO for Improved Cervical Cancer Screening in Ethiopia

Sponsor: Albert Einstein College of Medicine. Phase: NA. Conditions: Cervical Carcinoma, Human Papilloma Virus (HPV)

full page →ctgov ↗
›COMPLETEDphase readoutNCT00353158: A Pilot of Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of Phototoxicity

Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). Phase: PHASE1. Conditions: Healthy Volunteers, Fungal Infections, Bacterial Infections

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07598448: A Study of Complement 3 Glomerulopathy (C3G) Patients Treated With Iptacopan Through an Early Access Program in Spain

Sponsor: Novartis Pharmaceuticals. Phase: . Conditions: Complement 3 Glomerulopathy

full page →ctgov ↗
›RECRUITINGphase readoutNCT06527248: Nitrate, Exercise and Vascular Function in Midlife Women

Sponsor: University of Vienna. Phase: NA. Conditions: Healthy, Menopause, Hypertension, Inflammation

full page →ctgov ↗
›COMPLETEDphase readoutNCT07059455: Erector Spınae Plane Block and Transmuscular Quadratus Lumborum Block In Kıdney Transplantatıon

Sponsor: Kocaeli Derince Education and Research Hospital. Phase: NA. Conditions: Kidney Transplant

full page →ctgov ↗
›COMPLETEDphase readoutNCT00055055: Study of Families With Twins or Siblings Discordant for Rheumatic Disorders

Sponsor: National Institute of Environmental Health Sciences (NIEHS). Phase: . Conditions: Rheumatoid Arthritis, Systemic Lupus Erythematosus, Idiopathic Inflammatory Myopathies

full page →ctgov ↗
›RECRUITINGphase readoutNCT06284655: The Effect of a Brief Educational Intervention for Adults With ADHD

Sponsor: St. Olavs Hospital. Phase: NA. Conditions: ADHD

full page →ctgov ↗
›COMPLETEDphase readoutNCT05925855: Effect of Phonophoresis on Trigger Points

Sponsor: Batterjee Medical College. Phase: NA. Conditions: Trigger Point Pain, Myofascial

full page →ctgov ↗
›COMPLETEDphase readoutNCT04975555: Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity (ICANS) Related to CAR-T Cell Therapy

Sponsor: University of Alabama at Birmingham. Phase: PHASE2. Conditions: Cytokine Release Syndrome, ICANS, Lymphoma, Non-Hodgkin, Multiple Myeloma, Acute Lymphoblastic Leukemia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07633626: Vortioxetine for Cognitive Function in ALK-positive NSCLC Treated With Lorlatinib

Sponsor: Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo. Phase: . Conditions: Advanced ALK/ROS1-positive NSCLC, Carcinoma, Non-Small-Cell Lung (NSCLC), Lung Adenocarcinoma, ALK-positive Non-small Cell Lung Cancer (NSCLC), Cognitive Dysfunction, Depression

full page →ctgov ↗
›COMPLETEDphase readoutNCT07559526: Nutritional Assessment of Patients With Non-small Cell Lung Cancer Treated With Osimertinib

Sponsor: Fundacin Biomedica Galicia Sur. Phase: . Conditions: Non-small-cell Lung Cancer, Sarcopenia, Quality of Life

full page →ctgov ↗
›RECRUITINGphase readoutNCT07359443: Combination of Chemotherapy and Adaptive MR-Guided Radiotherapy to Improve Outcomes in Patients With Esophageal Adenocarcinoma

Sponsor: UMC Utrecht. Phase: PHASE1. Conditions: Esophageal Adenocarcinoma, Esophageal Adenocarcinoma (EAC), Adenocarcinoma - Gastroesophageal Junction (GEJ)

full page →ctgov ↗
›RECRUITINGphase readoutNCT05534243: The ED-AWARENESS-2 Trial

Sponsor: Washington University School of Medicine. Phase: NA. Conditions: Awareness, Mechanical Ventilation, Intubation Complication, PTSD

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07429643: Endoscopic Ultrasound-Guided Loco-regional Chemotherapy Injection as Adjuvant Therapy for Locally Advanced Pancreatic Cancer.

Sponsor: Assiut University. Phase: PHASE2. Conditions: Locally Advanced Pancreatic Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07526415: Effect of Recording Duration on Heart Rate Variability During taVNS

Sponsor: Sinop University. Phase: NA. Conditions: Healthy Volunteers

full page →ctgov ↗
›COMPLETEDphase readoutNCT03848715: Sleep and Healthy Aging Research on Depression for Younger Women

Sponsor: University of California, Los Angeles. Phase: PHASE1. Conditions: Anhedonia, Depression

full page →ctgov ↗
›COMPLETEDphase readoutNCT06422767: Study to Evaluate the Effect of Bepirovirsen on Cardiac Conduction as Assessed by 12-lead Electrocardiogram in Healthy Volunteers

Sponsor: GlaxoSmithKline. Phase: PHASE1. Conditions: Hepatitis B

full page →ctgov ↗
›RECRUITINGphase readoutNCT05990465: LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies

Sponsor: Medical College of Wisconsin. Phase: PHASE1. Conditions: Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Marginal Zone Lymphoma, Mantle Cell Lymphoma, Burkitt Lymphoma

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04509700: Rollover Study to Provide Continued Treatment for Participants With B-Cell Malignancies Previously Enrolled in Studies of Parsaclisib (INCB050465)

Sponsor: Incyte Corporation. Phase: PHASE2. Conditions: B-Cell Malignancies

full page →ctgov ↗
›COMPLETEDphase readoutNCT07522307: Psychological Impact of an 80-km Ultra-Endurance Race

Sponsor: Centre Hospitalier Régional d'Orléans. Phase: . Conditions: Healthy Adult Participants

full page →ctgov ↗
›COMPLETEDphase readoutNCT04090307: Targeted Lifestyle Change Group Prenatal Care

Sponsor: University of North Carolina, Chapel Hill. Phase: NA. Conditions: Pregnancy, Gestational Diabetes

full page →ctgov ↗
›RECRUITINGphase readoutNCT06692192: The RECAP2 Study: Midazolam and Psilocybin

Sponsor: University of Wisconsin, Madison. Phase: PHASE1. Conditions: Psilocybin

full page →ctgov ↗
›RECRUITINGphase readoutNCT05020236: A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments

Sponsor: Pfizer. Phase: PHASE3. Conditions: Multiple Myeloma

full page →ctgov ↗
›COMPLETEDphase readoutNCT07416136: The Aim of This Study is to Compare the Effects of Two Different Topical Agents (KLOROBEN® and KLORHEX PLUS®) Used in the Surgical Extraction of Mandibular Bilateral Mesioangular Impacted Third Molars on Postoperative Pain, Edema, and Trismus.

Sponsor: Marmara University. Phase: NA. Conditions: Impacted Mandibular Third Molar

full page →ctgov ↗
›RECRUITINGphase readoutNCT07399236: AI-Based Prediction of Liver Metastasis in Colorectal Cancer (A Retrospective Study)

Sponsor: Tongji Hospital. Phase: . Conditions: Colorectal Cancer Liver Metastases (CRLM)

full page →ctgov ↗
›COMPLETEDphase readoutNCT05799911: Effect of Molecular Hydrogen Administration on Performance and Body Response on Exercise in National-level Fin-swimmers

Sponsor: Palacky University. Phase: NA. Conditions: Athletic Performance, Muscle Fatigue, Oxidative Stress

full page →ctgov ↗
›COMPLETEDphase readoutNCT07659171: Light Therapy for University Students

Sponsor: Reykjavik University. Phase: NA. Conditions: University Students, Sleep Problems, Well-being, Concentration Performance, Depression and Anxiety Symptom

full page →ctgov ↗
›RECRUITINGphase readoutNCT04598009: Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma

Sponsor: University of California, San Francisco. Phase: PHASE2. Conditions: Melanoma Stage III, Melanoma Stage IV

full page →ctgov ↗
›COMPLETEDphase readoutNCT03961009: Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in PID Patients

Sponsor: Kedrion S.p.A.. Phase: PHASE3. Conditions: Primary Immunodeficiency Disease

full page →ctgov ↗
›COMPLETEDphase readoutNCT04701632: Prevalence and Variables Associated With Depression in Subjects With Chronic Wounds Using PHQ-9 as a Screening Tool

Sponsor: Methodist Health System. Phase: . Conditions: Wound

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06754163: Evaluating the Effect of the STEP@STAH Semaglutide Protocol on the Physical Health Measures of Atypical Antipsychotic-Treated Patients

Sponsor: St Andrew's Healthcare. Phase: PHASE4. Conditions: Obesity and Obesity-related Medical Conditions, Psychiatric Disorders

full page →ctgov ↗
›TERMINATEDphase readoutNCT04361487: Circumferential Compression STITCH Repairs of Complex and Horizontal Cleavage Meniscal Tears

Sponsor: Smith & Nephew, Inc.. Phase: . Conditions: Meniscus Tear, Retention; Meniscus

full page →ctgov ↗
›COMPLETEDphase readoutNCT05625893: Proton Beam Radiotherapy Followed by Tecentriq and Avastin for Primary Liver Cancer With Vp2-4 Portal Vein Invasion

Sponsor: Samsung Medical Center. Phase: PHASE2. Conditions: Hepatocellular Carcinoma, Portal Vein Thrombosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT03675893: RESOLVE: Abemaciclib + Letrozole +/- Metformin or Gedatolisib in Endometrial Cancer

Sponsor: Dana-Farber Cancer Institute. Phase: PHASE2. Conditions: Endometrial Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07463014: Peer Enriched Environment for Recovery (PEER)

Sponsor: Nanyang Technological University. Phase: NA. Conditions: Stroke

full page →ctgov ↗
›RECRUITINGphase readoutNCT06364306: oPen Versus RobotIc retrOmuscular Repair in Medium to Large Ventral Hernias

Sponsor: University Hospital, Basel, Switzerland. Phase: NA. Conditions: Ventral Hernia, Incisional Hernia, Abdominal Wall Defect

full page →ctgov ↗
›RECRUITINGphase readoutNCT07697404: The ED95 of Ciprofol for Laryngeal Mask Airway Insertion With Fentanyl in Children: A Biased-Coin Dose-Finding Trial

Sponsor: Huazhong University of Science and Technology. Phase: PHASE4. Conditions: Pediatric, Anesthesia Induction, Ciprofol, Laryngeal Mask Airway

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07553884: Baseline Knowledge of Stress Urinary Incontinence Among Urogynecology Patients

Sponsor: Sunnybrook Health Sciences Centre. Phase: . Conditions: Stress Urinary Incontinence (SUI)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07712133: Improving Radon Education and Awareness in Cancer Patients and Their Extended Community

Sponsor: University of Utah. Phase: NA. Conditions: Cancer Survivorship

full page →ctgov ↗
›RECRUITINGphase readoutNCT07315633: An Innovative CFD-based Dosimetry and Pre-treatment Planning Platform to Support Personalized Transarterial Therapies for Liver Cancer

Sponsor: University Hospital, Ghent. Phase: . Conditions: Hepatocellular Carcinoma (HCC), Liver Cancer, Adult, Liver Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07430033: Effectiveness of Online-Based "Pregnant Women Care Cadres" Intervention on Husband Support in Early Detection of High Risk in Medan Maimun Area

Sponsor: Siti Saidah Nasution. Phase: NA. Conditions: Pregnancy

full page →ctgov ↗
›RECRUITINGphase readoutNCT07018752: A Platform Trial Evaluating New Drugs or Combination in R/R Peripheral T-cell Lymphomas

Sponsor: The Lymphoma Academic Research Organisation. Phase: PHASE1. Conditions: Peripheral T Cells Lymphoma (PTCL)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07358533: Metabolic Obesity in Normal Weight (MONW): Diagnostic Markers Stud

Sponsor: Pomeranian Medical University Szczecin. Phase: . Conditions: Normal Weight Obesity, Metabolically Obese Normal Weight, Metabolic Syndrome

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07418333: Efficacy of EPD-09-25 for Eyelid Hygiene Before and After Eye Surgery.

Sponsor: VISUfarma SpA. Phase: NA. Conditions: Cataract Surgery, Ocular Infections

full page →ctgov ↗
← prev
page 116 of 117
next →